Sinequan: Advanced Relief for Depression and Anxiety Disorders
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.30 | $54.24 (0%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $108.48 $97.43 (10%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.98 | $59.26 (0%) | 🛒 Add to cart |
| 60 | $1.49 | $118.53 $89.40 (25%) | 🛒 Add to cart |
| 90 | $1.34 | $177.79 $120.54 (32%) | 🛒 Add to cart |
| 120 | $1.26 | $237.06 $151.68 (36%) | 🛒 Add to cart |
| 180 | $1.18 | $355.59 $212.95 (40%) | 🛒 Add to cart |
| 270 | $1.13 | $533.38 $306.37 (43%) | 🛒 Add to cart |
| 360 | $1.11
Best per pill | $711.17 $400.79 (44%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.74 | $52.23 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $104.47 $82.37 (21%) | 🛒 Add to cart |
| 90 | $1.26 | $156.70 $113.51 (28%) | 🛒 Add to cart |
| 180 | $1.14 | $313.40 $205.92 (34%) | 🛒 Add to cart |
| 270 | $1.10 | $470.10 $298.33 (37%) | 🛒 Add to cart |
| 360 | $1.08
Best per pill | $626.80 $389.74 (38%) | 🛒 Add to cart |
Synonyms | |||
Sinequan (doxepin hydrochloride) is a tricyclic antidepressant (TCA) with a well-established profile for managing major depressive disorder and anxiety-related conditions. As a potent serotonin and norepinephrine reuptake inhibitor, it offers a dual mechanism of action that supports mood stabilization and reduces excessive worry. Its sedative properties also make it particularly useful for patients experiencing sleep disturbances associated with depression. Clinicians value Sinequan for its predictable pharmacokinetics and decades of evidence supporting its efficacy in both acute and maintenance therapy.
Features
- Active ingredient: Doxepin hydrochloride
- Available in 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg capsules
- Also available as an oral concentrate (10 mg/mL)
- Chemical class: Dibenzoxepin-derived tricyclic antidepressant
- Half-life: Approximately 15–30 hours for doxepin and its active metabolite
- Metabolism: Hepatic, primarily via CYP2D6 and CYP2C19
Benefits
- Provides significant relief from symptoms of major depressive disorder, including low mood, anhedonia, and fatigue.
- Effectively reduces anxiety, agitation, and psychic tension associated with generalized anxiety disorder.
- Improves sleep architecture by decreasing sleep latency and reducing nighttime awakenings.
- Offers a cost-effective treatment option with established long-term safety data.
- May be used off-label for certain chronic pain conditions and dermatological disorders (e.g., pruritus).
- Supports functional recovery and improves overall quality of life in responsive patients.
Common use
Sinequan is primarily indicated for the treatment of major depressive disorder and anxiety disorders. It is also used off-label for conditions such as neuropathic pain, fibromyalgia, insomnia, and chronic urticaria. Its sedating effects make it particularly useful for patients with comorbid sleep disturbances. Clinicians may also consider it for treatment-resistant cases where SSRIs have proven ineffective.
Dosage and direction
Initial dosing for depression in adults typically begins at 75 mg/day, administered in divided doses or as a single daily dose at bedtime. Dosage may be gradually increased to a maximum of 300 mg/day for hospitalized patients, or 150 mg/day for outpatients, based on tolerance and therapeutic response. For milder cases or geriatric patients, initial doses as low as 25–50 mg/day are recommended. The oral concentrate should be diluted with 4 oz of water, milk, or juice (not carbonated beverages) prior to administration. Dosage adjustments are necessary in patients with hepatic impairment.
Precautions
Patients should be advised that Sinequan may impair mental or physical abilities required for driving or operating machinery. Alcohol should be avoided due to additive CNS depression. Caution is advised in patients with a history of seizures, cardiovascular disease, urinary retention, or angle-closure glaucoma. Regular monitoring of blood pressure and heart rate is recommended, especially during dose titration. Abrupt discontinuation should be avoided; taper gradually over at least two weeks.
Contraindications
Sinequan is contraindicated in individuals with known hypersensitivity to doxepin or other dibenzoxepines. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. Additional contraindications include recent myocardial infarction, untreated narrow-angle glaucoma, and severe urinary retention.
Possible side effect
Common side effects include dry mouth, drowsiness, constipation, blurred vision, and weight gain. Less frequently, patients may experience orthostatic hypotension, tachycardia, sweating, or dizziness. Rare but serious adverse effects include leukopenia, agranulocytosis, hepatitis, and seizures. Any signs of allergic reaction (e.g., rash, urticaria) should prompt immediate medical attention.
Drug interaction
Sinequan has significant interactions with MAOIs, SSRIs, SNRIs, triptans, and other serotonergic drugs, increasing the risk of serotonin syndrome. It may potentiate the effects of CNS depressants including alcohol, benzodiazepines, and opioids. Concomitant use with anticholinergics may lead to additive side effects. CYP2D6 inhibitors (e.g., fluoxetine, quinidine) can increase doxepin plasma concentrations. Use with caution in patients taking anticoagulants due to possible potentiation of warfarin effect.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose is not recommended.
Overdose
Symptoms of overdose may include severe drowsiness, blurred vision, dry mouth, tachycardia, hypotension, respiratory depression, confusion, seizures, and coma. ECG changes such as QRS widening may occur. Management includes gastric lavage, activated charcoal, and supportive care. Sodium bicarbonate may be used to correct acidosis and narrow QRS duration. There is no specific antidote.
Storage
Store at room temperature (20–25°C or 68–77°F) in a tightly closed container. Protect from light and moisture. Keep out of reach of children and pets. Do not freeze the oral concentrate.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis and treatment recommendations. Individual response to medication may vary.
Reviews
Clinical studies and decades of use support Sinequan’s efficacy in treating depression and anxiety. Many clinicians report good patient response, particularly in cases with prominent sleep disturbances. Some patients note initial drowsiness that often diminishes with continued use. Long-term users appreciate its sustained effect, though weight gain and anticholinergic side effects are occasionally reported as drawbacks.